The latest closing stock price for Cadrenal Therapeutics as of January 21, 2025 is 17.40.
An investor who bought $1,000 worth of Cadrenal Therapeutics stock at the IPO in 2023 would have $3,223 today, roughly 3 times their original investment - a 105.51% compound annual growth rate over 2 years.
The all-time high Cadrenal Therapeutics stock closing price was 18.20 on January 16, 2025.
The Cadrenal Therapeutics 52-week high stock price is 19.97, which is 14.8% above the current share price.
The Cadrenal Therapeutics 52-week low stock price is 0.36, which is 97.9% below the current share price.
The average Cadrenal Therapeutics stock price for the last 52 weeks is 5.98.
An investor who bought $1,000 worth of Cadrenal Therapeutics stock at the IPO in 2023 would have $3,223 today, roughly 3 times their original investment - a 105.51% compound annual growth rate over 2 years.
The all-time high Cadrenal Therapeutics stock closing price was 18.20 on January 16, 2025.
The Cadrenal Therapeutics 52-week high stock price is 19.97, which is 14.8% above the current share price.
The Cadrenal Therapeutics 52-week low stock price is 0.36, which is 97.9% below the current share price.
The average Cadrenal Therapeutics stock price for the last 52 weeks is 5.98.